Accès ouvert
2025
article
OpenAlex
Lie Ma, Brent H. Koehn, Michael Zaiken, Keli L. Hippen et autres
ABSTRACT: Front-line pharmaceutical interventions for treating acute graft-versus-host disease (GVHD) are not uniformly effective and have toxic side effects. Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells with potent in vitro and in vivo immunosuppressive functions. Clinical translation …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Elizabeth C. Nowak, Jiannan Li, Zachary T. Peters, Lindsay Mendyka et autres
A growing body of evidence suggests that the immune checkpoint inhibitory receptor VISTA plays a central role in the regulation of innate immunity in the settings of inflammatory diseases and cancer. Neutrophils are among the cells that have the highest membrane density …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Jordan N. Fink, Yao Ke, Cameron McDonald-Hyman, Phillip M. Dougherty et autres
Non-lymphoid immunoregulatory cells, including mesenchymal stem cells (MSCs), myeloid-derived suppressor cells (MDSCs), regulatory macrophages (Mregs), and tolerogenic dendritic cells (Tol-DCs), play critical roles in maintaining immune homeostasis. However, their therapeutic application in autoimmune diseases and graft-versus-host disease (GVHD) has received comparatively less …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Brent H. Koehn, Elizabeth C. Nowak, Sladjana Skopalja-Gardner, Asim Saha et autres
ABSTRACT: The success of allogeneic hematopoietic stem cell transplantation (allo-HSCT) can be limited by graft-versus-host disease (GVHD). T-cell activation is a key factor in GVHD progression. Costimulatory signals can be counterbalanced by coinhibitory signals such as the checkpoint molecule VISTA (V-domain immunoglobulin-containing …
us, fr
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Michael Zaiken, Sujeong Jin, Cameron McDonald-Hyman, Christina R. Hartigan et autres
ABSTRACT: Chronic graft-versus-host disease (cGVHD) is the leading cause of morbidity and nonrelapse-associated mortality after allogeneic hematopoietic cell transplantation. Treating steroid resistant/refractory cGVHD remains challenging. Epigenetic regulators can have global transcriptional effects that control donor T-cell responses. We previously showed that inhibiting …
us
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
Elizabeth C. Nowak, Jiannan Li, Mohamed ElTanbouly, Wilson L. Davis et autres
Abstract A growing body of evidence suggests that VISTA, an immune checkpoint inhibitory receptor, plays a central role in the regulation of innate immunity in the settings of inflammatory diseases and cancer. Neutrophils are among the cells that have the highest membrane …
us, ca
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Jemma H. Larson, Sujeong Jin, Michaël Loschi, Sara Bolivar-Wagers et autres
Damage to the gastrointestinal tract following allogeneic hematopoietic stem cell transplantation is a significant contributor to the severity and perpetuation of graft-versus-host disease. In preclinical models and clinical trials, we showed that infusing high numbers of regulatory T cells reduces graft-versus-host disease …
us, au
(code pays fourni par la source)
2023
book-chapter
OpenAlex
Govindarajan Thangavelu, Sara Bolivar-Wagers, Ethan G. Aguilar, Stephanie Y. Rhee et autres
us
(code pays fourni par la source)
2023
paratext
OpenAlex
Ethan G. Aguilar, Farah Asa’ad, Kiandokht Bashiri, Rasheedunnisa Begum et autres
us, se, ca, in, nl, co, it, es, my, de, mx
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Teresa Lopes Ramos, Sara Bolivar-Wagers, Sujeong Jin, Govindarajan Thangavelu et autres
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative option for patients with hematological disorders and bone marrow (BM) failure syndromes. Graft-versus-host disease (GVHD) remains a leading cause of morbidity posttransplant. Regulatory T cell (Treg) therapies are efficacious in ameliorating GVHD but …
us, ch, jp
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Sara Bolivar-Wagers, Michaël Loschi, Sujeong Jin, Govindarajan Thangavelu et autres
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) efficacy is complicated by graft-versus-host disease (GVHD), a leading cause of morbidity and mortality. Regulatory T cells (Tregs) have shown efficacy in preventing GVHD. However, high Treg doses are often required, necessitating substantial ex vivo or …
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Kelly Walton, Kirsti L. Walker, Megan Riddle, Brent H. Koehn et autres
Prevention of allograft rejection often requires lifelong immune suppression, risking broad impairment of host immunity. Nonselective inhibition of host T cell function increases recipient risk of opportunistic infections and secondary malignancies. Here we demonstrate that AJI-100, a dual inhibitor of JAK2 and …
us
(code pays fourni par la source)